{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:55:55Z","timestamp":1784339755892,"version":"3.55.0"},"reference-count":76,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"This paper was funded by Pfizer Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2022,7,3]]},"DOI":"10.1080\/14760584.2021.1894933","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T11:35:02Z","timestamp":1615203302000},"page":"885-898","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["A systematic literature review of economic evaluations of pneumococcal conjugate vaccines in east and southeast Asia (2006-2019)"],"prefix":"10.1080","volume":"21","author":[{"given":"Bruce Cm","family":"Wang","sequence":"first","affiliation":[{"name":"Health Economics and Real World Evidence , Elysia Group, LLC, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4572-8794","authenticated-orcid":false,"given":"Nathorn","family":"Chaiyakunapruk","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, University of Utah, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiqing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, Pfizer Investment Co. Ltd, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Babigumira","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley","family":"Furnback","sequence":"additional","affiliation":[{"name":"Health Economics and Real World Evidence , Elysia Group, LLC, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramaa","family":"Chitale","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amgad","family":"Gamil","sequence":"additional","affiliation":[{"name":"Medical and Scientific Affairs, Pfizer Inc, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Health Technology Assessment, China National Health Development Research Center, National Health Commission of the People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3300-2742","authenticated-orcid":false,"given":"Matt","family":"Wasserman","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30247-X"},{"key":"e_1_3_4_4_1","unstructured":"Unicef supply division\/\u201cpneumococcal conjugate vaccine: supply and deman update. Jul 2020. Available at: https:\/\/www.unicef.org\/supply\/sites\/unicef.org.supply\/files\/2020-07\/Pneumococcal-conjugate-vaccine-supply-update-July2020.pdfAccessed:August3 2020"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012488"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41479-019-0064-y"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1589287"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.2165\/11584930-000000000-00000"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2008.02.003"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.12.99"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1155\/2006\/835768"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-013-0113-y"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737167.8.4.373"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.10.034"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.01.081"},{"key":"e_1_3_4_16_1","doi-asserted-by":"crossref","unstructured":"Saokaew S Rayanakorn A Wu DB-C et al. Cost effectiveness of pneumococcal vaccination in children in low-and middle-income countries: a systematic review. Pharmacoeconomics. 2016;34(12):1211\u20131225. \u2022\u2022 Our review drew from the Saokaew et al (2016) which is a systematic literature review of PCV economic evaluations until 2015 focused on low and middle income countries","DOI":"10.1007\/s40273-016-0439-3"},{"key":"e_1_3_4_17_1","volume-title":"Methods for the economic evaluation of health care programmes","author":"Drummond MF","year":"1997","unstructured":"Drummond MF, O\u2019Brien B, Stoddart GL, et al. Methods for the economic evaluation of health care programmes. 2nd ed. ed. Oxford: Oxford University Press; 1997.","edition":"2"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.inhe.2011.08.004"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.inhe.2011.08.003"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30422-4"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-14-56"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.04.012"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1021-x"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.051"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001288"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201245"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1438794"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-248"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2014.04.008"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-017-0079-2"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1067351"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.02.033"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.03.052"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-014-0053-7"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2013.01.012"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2009.00626.x"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2010.16.1.32"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1362513"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.12.004"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2017-000636"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.11.013"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2011.10.006"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.06.015"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.03.047"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131156"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2014.04.004"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.06.091"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.12.070"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.02.048"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-015-0063-0"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120290"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70060-8"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.04.005"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1362339"},{"key":"e_1_3_4_55_1","unstructured":"De Melker HE Sanders EA van der Ende A. editors. Incidence of IPD in the Netherlands up to five years after introduction of PCV102016: national Institute for Public Health and the Environment"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.04.010"},{"key":"e_1_3_4_57_1","unstructured":"Belgium Superior Health Council. Infant Pneumococcal Vaccination 2018 [Dec 2018]. Available from: https:\/\/www.health.belgium.be\/en\/node\/34692."},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2019.1675521"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piw010"},{"key":"e_1_3_4_60_1","first-page":"13","volume-title":"The 9th International Symposium on Antimicrobial Agents and Resistance (ISAAR) March","author":"Saez-Llorens X","unstructured":"Saez-Llorens X, Castrejon M, Rowley S, et al. Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) against acute otitis media in children in Panama. Poster presentation. The 9th International Symposium on Antimicrobial Agents and Resistance (ISAAR) March 13\u201315, Kuala Lumpur, Malaysia."},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.12.086"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.05.041"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-015-0483-8"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis922"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001657"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010776"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2016.07.009"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1343773"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.016"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2011.622323"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.12.007"},{"key":"e_1_3_4_72_1","unstructured":"Joint Committee on Vaccination and Immunisation. Minutes of the JCVI pneumococcal subcommittee meeting 2012 May 30. http:\/\/webarchive.nationalarchives.gov.uk\/20130402145952\/http:\/transparency.dh.gov.uk\/2012\/07\/27\/jcvipneumococcal-sub-committee-meeting-may-2012\/"},{"key":"e_1_3_4_73_1","unstructured":"Joint Committee on Vaccination and Immunisation. Minutes of the JCVI meeting 2014Jun4. https:\/\/app.box.com\/s\/iddfb4ppwkmtjusir2tc#\/s\/iddfb4ppwkmtjusir2tc\/1\/2199012147\/19052160649\/1?&_suid=142195891623007725862911282104."},{"key":"e_1_3_4_74_1","unstructured":"Moore MR Update on effectiveness and impact of PCV13 use among U.S. children. [cited 2015 Jan 21]. Available from: http:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2014-02\/02-Pneumo-Moore.pdf.AccessedJan21 2015."},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31827e8594"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.068"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy920"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2014.04.007"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2021.1894933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T07:21:49Z","timestamp":1711005709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2021.1894933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":76,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,3]]}},"alternative-id":["10.1080\/14760584.2021.1894933"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2021.1894933","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-08-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}